Home · Blog · Research

New Drug Target EPAC2 Reverses Fragile X Syndrome Symptoms in Mice

New Drug Target EPAC2 Reverses Fragile X Syndrome Symptoms in Mice

UCLA researchers have identified a promising new drug target for Fragile X syndrome — the most common genetic cause of intellectual disability and autism. By blocking an overactive synaptic protein called EPAC2, they restored normal brain activity and reversed key behavioral symptoms in mice, offering hope for an effective therapy.

The Research

The study, published in Neuron and led by Dr. Anand Suresh and Dr. Carlos Portera-Cailliau of UCLA, used genetically engineered mice missing the FMR1 gene — the single-gene mutation that causes Fragile X in humans. Using advanced RNA sequencing to analyze gene activity separately in excitatory and inhibitory brain cells — the two systems whose imbalance is thought to drive the disorder — they discovered that EPAC2 levels were abnormally elevated at synapses across both cell types.

When the researchers blocked EPAC2 — either by genetically deleting the gene or by administering a drug compound — they observed a restoration of balanced neural circuit activity. The treated mice also showed marked improvements in three core behavioral deficits: hypersensitivity to touch, social interaction difficulties, and seizure susceptibility. EPAC2 is particularly attractive as a drug target because it is expressed almost exclusively in the brain, reducing the risk of side effects elsewhere in the body. The study also noted that EPAC2 levels rise gradually as the brain matures, suggesting that therapies targeting this protein could be effective for older children and adults, not just during early development.

Why It Matters

Fragile X syndrome affects about 1 in 2,000 boys and is a leading genetic cause of autism. Despite decades of research, no targeted therapy has succeeded in clinical trials. This discovery provides a clear molecular target — EPAC2 — that directly reverses the neurological and behavioral hallmarks of the condition. For anyone interested in brain health, this work underscores how a single protein can throw the brain's delicate excitatory-inhibitory balance out of whack, and how restoring that balance can have profound effects on cognition and behavior.

What You Can Do

While this research is still preclinical, it highlights the importance of maintaining a healthy brain balance. You can support your own cognitive function by engaging in activities that promote neural plasticity, such as learning new skills, getting regular exercise, and ensuring adequate sleep. For a baseline measure of your cognitive abilities, consider taking a validated IQ test.

Source: Neuroscience News

Curious about your own brain? Take our free adaptive IQ test or try 306 brain training levels.

Curious about your own IQ?

Take our free, scientifically designed adaptive test across 7 cognitive domains. No signup required.

Take the free test